| Trial ID: | L2863 |
| Source ID: | NCT00946972
|
| Associated Drug: |
Jnj-38431055; Placebo
|
| Title: |
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: JNJ-38431055; Placebo
|
| Outcome Measures: |
Primary: Adverse events, laboratory values, vital signs, ECGs, Throughout the study | Secondary: 24 hour weighted mean glucose, 24 hours|Fasting plasma glucose, glycosylated albumin, 14 days|Dose response, 14 days|Measures of beta-cell function, 14 days|Incretin levels, 14 days
|
| Sponsor/Collaborators: |
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
33
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-07
|
| Completion Date: |
2009-11
|
| Results First Posted: |
|
| Last Update Posted: |
2010-03-05
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00946972
|
